In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | S-1/A |
Revenues: |
Research and development | | | | | | | 11.4 |
Product revenue | | | | | | | 6.2 |
Other | | | | | | | 0.6 |
Total revenues [+] | 27.8 | 18.0 | 8.5 | 10.1 | 12.0 | 9.5 | 18.2 |
Royalties | | | | | | | 11.4 |
Products | | | | | | | 6.2 |
Revenue growth | 54.6% | 111.5% | -16.1% | -15.6% | 26.3% | -47.8% | |
Cost of goods sold [+] | 21.9 | 14.1 | 5.7 | 6.8 | 8.7 | 6.0 | 3.6 |
Cost of product sales | | | | | | | 3.5 |
Other cost of sales | | | | | | | 0.1 |
Gross profit | 5.9 | 3.9 | 2.8 | 3.4 | 3.3 | 3.5 | 14.6 |
Gross margin | 21.4% | 21.5% | 32.6% | 33.2% | 27.4% | 36.6% | 80.4% |
Selling, general and administrative | 88.6 | 58.5 | 31.1 | 20.2 | 14.2 | 14.1 | 13.0 |
Research and development | 49.0 | 22.5 | 10.3 | 9.1 | 9.5 | 12.0 | |
Other operating expenses | | | | | | | 22.9 |
EBITDA [+] | -122.1 | -73.8 | -37.1 | -24.7 | -19.1 | -21.1 | -20.1 |
EBITDA growth | 65.5% | 98.9% | 49.8% | 29.6% | -9.5% | 5.3% | |
EBITDA margin | -439.1% | -410.2% | -436.0% | -244.3% | -159.1% | -222.1% | -110.0% |
Depreciation | 3.8 | 2.0 | 1.4 | 1.1 | 1.3 | 1.5 | 1.1 |
EBITA | -125.9 | -75.7 | -38.5 | -25.9 | -20.4 | -22.6 | -21.2 |
EBITA margin | -452.8% | -421.0% | -452.2% | -255.4% | -170.1% | -237.9% | -116.2% |
Amortization of intangibles | 5.8 | 1.4 | 0.1 | | | | |
EBIT [+] | -131.7 | -77.1 | -38.6 | -25.9 | -20.4 | -22.6 | -21.2 |
EBIT growth | 70.8% | 100.0% | 49.0% | 26.7% | -9.7% | 6.8% | |
EBIT margin | -473.7% | -428.8% | -453.4% | -255.4% | -170.1% | -237.9% | -116.2% |
Non-recurring items [+] | | | | | | 0.6 | |
Asset impairment | | | | | | 0.6 | |
Interest expense, net [+] | -1.2 | 0.5 | 2.5 | 2.3 | 1.4 | 0.6 | 0.5 |
Interest expense | 0.3 | 0.9 | 2.5 | 2.3 | 1.4 | 0.6 | 0.5 |
Interest income | 1.5 | 0.4 | | | | | |
Other income (expense), net [+] | -0.2 | -0.5 | 0.0 | -1.6 | 3.3 | 0.5 | 2.8 |
Gain (loss) on debt retirement | | -2.1 | | -1.3 | -0.3 | | |
Change in fair value of warrants | | | | | 4.0 | 0.8 | |
Other non-ooperating expenses | | | | -0.3 | -0.3 | -0.3 | |
Other | -0.2 | -0.1 | 0.0 | 0.3 | 0.3 | 0.3 | 0.2 |
Pre-tax income | -130.7 | -78.2 | -41.1 | -29.8 | -18.5 | -23.3 | -18.8 |
Income taxes | 1.9 | -5.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | 7.3% | | | | | 0.1% |
Net income | -132.6 | -72.4 | -41.1 | -29.8 | -18.5 | -23.4 | 0.0 |
Net margin | -476.9% | -402.8% | -483.4% | -294.3% | -154.1% | -245.8% | 0.0% |
|
Basic EPS [+] | ($0.46) | ($0.26) | ($0.39) | ($1.99) | ($2.61) | ($8.65) | $0.00 |
Growth | 75.2% | -33.6% | -80.2% | -23.8% | -69.8% | | |
Diluted EPS [+] | ($0.46) | ($0.26) | ($0.39) | ($1.99) | ($2.61) | ($8.65) | $0.00 |
Growth | 75.2% | -33.6% | -80.2% | -23.8% | -69.8% | | |
|
Shares outstanding (basic) [+] | 289.2 | 276.8 | 104.3 | 15.0 | 7.1 | 2.7 | 60.3 |
Growth | 4.5% | 165.5% | 596.0% | 111.6% | 162.0% | -95.5% | |
Shares outstanding (diluted) [+] | 289.2 | 276.8 | 104.3 | 15.0 | 7.1 | 2.7 | 60.3 |
Growth | 4.5% | 165.5% | 596.0% | 111.6% | 162.0% | -95.5% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |